Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

被引：0
|
作者：
Y-K Kang
H-M Chang
J H Yook
M-H Ryu
I Park
Y J Min
D Y Zang
G Y Kim
D H Yang
S J Jang
Y S Park
J-L Lee
T W Kim
S T Oh
B K Park
H-Y Jung
B S Kim
机构：
[1] Asan Medical Center,Department of Oncology
[2] University of Ulsan College of Medicine,Department of Surgery
[3] 88,Department of Internal Medicine
[4] Olympic-ro 43-gil,Department of Internal Medicine
[5] Songpa-gu,Department of Surgery
[6] Seoul 138-736,Department of Surgery
[7] Korea,Department of Pathology
[8] Asan Medical Center,Departments of Gastroenterology
[9] University of Ulsan College of Medicine,undefined
[10] Ulsan University Hospital,undefined
[11] University of Ulsan College of Medicine,undefined
[12] Hallym University Sacred Heart Hospital,undefined
[13] Hallym University College of Medicine,undefined
[14] Ulsan University Hospital,undefined
[15] University of Ulsan College of Medicine,undefined
[16] Hallym University Sacred Heart Hospital,undefined
[17] Hallym University College of Medicine,undefined
[18] Asan Medical Center,undefined
[19] University of Ulsan College of Medicine,undefined
[20] LSK Global Pharma Services,undefined
[21] Asan Medical Center,undefined
[22] University of Ulsan College of Medicine,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
mitomycin-C; doxifluridine; cisplatin; adjuvant chemotherapy; gastric cancer; D2 gastrectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1251
页数：6
相关论文
共 50 条
  • [21] Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang, Yung-Jue
    Kim, Young-Woo
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Park, Young-Kyu
    Lee, Kyung Hee
    Lee, Keun-Wook
    Kim, Yong Ho
    Noh, Sang-Ik
    Cho, Jae Yong
    Mok, Young Jae
    Kim, Yeul Hong
    Ji, Jiafu
    Yeh, Ta-Sen
    Button, Peter
    Sirzen, Florin
    Noh, Sung Hoon
    LANCET, 2012, 379 (9813): : 315 - 321
  • [22] The initial results for a phase III study of short-term radiotherapy plus chemotherapy vs long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR trial)
    Jin, Jing
    Jin, Jing
    Tang, Y.
    Li, S.
    Li, N.
    Ren, H.
    Zhang, H-Z
    Zhou, Z-X
    Liang, J-W
    Zheng, Z-X
    Zhao, D-B
    Zhang, H-M
    Zou, S-M
    Fang, H.
    Chi, Y-H-B-L
    Yang, L.
    Wang, W-H
    Song, Y-W
    Liu, Y-P
    Wang, S-L
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [24] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer
    Wang, Yawei
    Wang, Yan
    Wu, Wang
    Lu, Xiaofang
    An, Tailai
    Jiang, Jiling
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [27] Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer
    Yawei Wang
    Yan Wang
    Wang Wu
    Xiaofang Lu
    Tailai An
    Jiling Jiang
    World Journal of Surgical Oncology, 19
  • [28] Laparoscopic D2 plus complete mesogastrium excision using the "enjoyable space" approach versus conventional D2 total gastrectomy for local advanced gastric cancer: short-term outcomes
    Zheng, Chang-Yue
    Dong, Zhi-Yong
    Dong, Zhiyong
    Qiu, Xian-Tu
    Zu, Bin
    Xu, Rui
    Lin, Wei
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2020, 15 (01) : 58 - 69
  • [29] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Matsuyama, Jin
    Imamura, Hiroshi
    Yamamoto, Kazuyoshi
    Fujita, Junya
    Iijima, Shohei
    Ueda, Shugo
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2020, 23 (03) : 520 - 530
  • [30] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Ryohei, Kawabata
    Kazumasa, Fujitani
    Shigeyuki, Tamura
    Yutaka, Kimura
    Hiroshi, Imamura
    Junya, Fujita
    Jin, Matsuyama
    Shohei, Iijima
    Shugo, Ueda
    Yukinori, Kurokawa
    Daisuke, Sakai
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    Taroh, Satoh
    ANNALS OF ONCOLOGY, 2017, 28
12345